Cisplatin-based chemotherapy in elderly patients with advanced stage (IIIB and IV) non-small cell lung cancer patients

Neoplasma

Volumn 58, Issue 4, 2011, Pages 348-351

  Ozkaya, S ^a   Findik, S ^b   Atici, A G ^b   Dirican, A ^c  

^a RECEP TAYYIP ERDOGAN UNIVERSITY   (Turkey)

^b ONDOKUZ MAYIS UNIVERSITY   (Turkey)

^c Medicalpark Hospital   (Turkey)

Author keywords

Chemotherapy; Cisplatin; Elderly; Non small cell lung cancer

Indexed keywords

CISPLATIN; GEMCITABINE; NAVELBINE; ANTINEOPLASTIC AGENT;

ADULT; ADVANCED CANCER; AGED; ANEMIA; ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER STAGING; CANCER SURVIVAL; CHEMORADIOTHERAPY; CONTROLLED STUDY; DRUG EFFICACY; DRUG TOLERABILITY; FEBRILE NEUTROPENIA; FEMALE; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; NAUSEA AND VOMITING; NEUTROPENIA; RETROSPECTIVE STUDY; SURVIVAL RATE; THROMBOCYTOPENIA; AGE; KAPLAN MEIER METHOD; LUNG TUMOR; MIDDLE AGED; MORTALITY; MULTIMODALITY CANCER THERAPY; PATHOLOGY; RADIOTHERAPY;

AGE FACTORS; AGED; ANTINEOPLASTIC AGENTS; CARCINOMA, NON-SMALL-CELL LUNG; CISPLATIN; COMBINED MODALITY THERAPY; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; RADIOTHERAPY; RETROSPECTIVE STUDIES;

EID: 80052528470     PISSN: 00282685     EISSN: None     Source Type: Journal    
DOI: 10.4149/neo_2011_04_348     Document Type: Article

References (13)

1. GRIDELLI C, MAIONE P, COMUNALE D, ROSSI A. Adju-vant Chemotherapy in Elderly Patients with Non-Small-Cell Lung Cancer. Cancer Control 2007;14:57-62.
2. Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials. Non-small Cell Lung Cancer Collaborative Group. BMJ 1995;311:899-909.
3. Gridelli C, Perrone F, Gallo C, Cigolari S, Rossi A, et al. Chemotherapy for Elderly Patients With Advanced Non Small Cell Lung Cancer in the Elderly Study (MILES) Phase III Randomized Trial J Natl Cancer Inst 2003;95:362-372.
4. PARKIN DM. Global cancer statistics in year 2000. Lancet Oncol. 2001;2:533-543. doi:10.1016/S1470-2045(01)00486-7
5. EARLE CC, VENDITTI LN, NEUMANN PJ, GELBER RD, WEINSTEIN MC, et al: Who gets chemotherapy for metastatic lung cancer? Chest 117: 1239-1246, 2000. doi:10.1378/chest.117.5.1239
6. EARLE CC, NEUMANN PJ, GELBER RD, WEINSTEIN MC, WEEKS JC. Impacts of referral patterns on the use of chemotherapy for lung cancer. J Clin Oncol 2002;20:1786-92.
7. LANGER CJ, MANOLA J, BERNARDO P, KUGLER JW, BONOMI P, et al. Cisplatin-based therapy for elderly patients with advanced non-small-cell lung cancer: implacations of Eastern Cooperative Oncology Group 5592, a randomized trial. J Natl Cancer Inst. 2002;94:173-181.
8. LANGER CJ, VANGEL M, SCHILLER J, HARRINGTON P, SANDLER A, et al. Age-spesific subanalysis of ECOG 1594; fit elderly patients (70-80 yrs) with NSCLC do as well as younger pts (<70). Proc Annu Meet Am Soc Clin Oncol. 2003;22:2571 [Abstract].
9. KELLY K, GIARRITTA S, HAYES S, AKERLEY W, Hes-Keth P, et al. Should older patients (pts) receive combination chemotherapy for advanced stage non-small cell lung cancer (NSCLC)? An analysis of Southwest Oncology trials 9509 and 9308. Proc Annu Meet Am Soc Clin Oncol. 2001;20:1313 [Abstract].
10. BELANI CP, FOSSELLA FV. Phase III study (TAX 326) of docetaxel-cisplatin and docetaxel-carboplatin vs vinorelbine-cisplatin fort he first-line treatment of advanced/ metastatic non-small cell lung cancer: analyses in elderly patients. Lung Cancer 2003;41(suppl 2):S18. doi:10.1016/ S0169-5002(03)91709-0
11. LILENBAUM RC, HERNDON JE, LIST MA, DESCH C, WATSONN DM, et al. Single-agent vs combination chemotherapy in advanced non-small cell lung cancer: The Cancer and Leukemia Group B (study 9730). J Clin Oncol. 2005;23:190-196. doi:10.1200/JCO.2005.07.172
12. SCHILD SE, STELLA PJ, SUSAN SG, BONNER JA, McGIN-Nis WL, et al. The outcome of combined-modality therapy for stage III non-small cell lung cancer in the elderly. J Clin Oncol 2003;21:3201-3206. doi:10.1200/JCO.2003.12.019
13. HENNESY BT, HANRAHAN EO, BREATHNACH OS. Chemotherapy Options for the Elderly Patient with Advanced Non-Small Cell Lung Cancer. The Oncologist 2003;8:270-277. doi:10.1634/theoncologist.8-3-270